medigraphic.com
ISSN 0301-696X (Print)
Órgano de difusión del Servicio de Sanidad Militar y del Colegio Nacional de Médicos Militares

2019, Number 2

<< Back Next >>

Rev Sanid Milit Mex 2019; 73 (2)

Prevalence of overactive bladder syndrome and associated comorbidities in patients from a climacteric clinic

Robles-Mejía M, Rodríguez-Ayala C, González-Aldeco PM

Language: Spanish
References: 21
Page: 120-125
PDF size: 234.78 Kb.


ABSTRACT

Introduction: Overactive bladder (OAB) is a prevalent condition which significantly impairs quality of life. Objective: The objective of the present study was to evaluate the prevalence and comorbidities associated to OAB in women who attend the climacteric clinic. Material and methods: Observational study in women who attended the climacteric clinic in september 2014. Patients were asked to answer the «Bladder Control Self-assessment Questionnarie» (B-SAQ) and we collected clinical and biochemical data from each participant. Patients were classified as those with OAB and a control group according to their individual score on the PPBC. Results: 42 patients were included in the study. Among these, 15 were diagnosed with OAB (score › 6 on PPBC), while 27 were considered control subjects (score ‹ 6 on PPBC). The average PPBC score for patients with OAB was 9.93 ± 3.20 compared to 1.77 ± 2.25 for control subjects. Average age was similar between both groups (55 [OAB] vs 54 [control]). Compared to the control group patients with OAB had a significantly higher BMI (31.7 ± 5.86 vs 27.5 ± 3.01; p = 0.021), as well as thyroid dysfunction (46% vs 14.8%; p = 0.050). Conclusions: Prevalence of OAB in women who attend the climacteric clinic was high at 37.5%, and is associated with specific comorbidities.


REFERENCES

  1. Haylen BT, de Ridder D, Freeman RM et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010; 21: 5-26.

  2. Irwin DE, Milsom I, Hunskaar S et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006; 50: 1306-1314; discussion 1314-1305.

  3. Velázquez MM. Prevalencia y calidad de vida en mujeres con incontinencia urinaria. Estudio en población abierta. Ginecol Obstet Mex. 2007; 75: 347-356.

  4. Ipsos/Bimsa. Estudio sobre prevalencia de vejiga hiperactiva y diferentes tipos de incontinencia urinaria en la población femenina urbana mexicana. 2005.

  5. Wallace KM, Drake MJ. Overactive bladder. Maturitas. 2010; 257-262.

  6. Uzun H, Zorba OU. Metabolic syndrome in female patients with overactive bladder. Urology. 2012; 79: 72-75.

  7. Palleschi G, Pastore AL, Maggioni C et al. Overactive bladder in diabetes mellitus patients: a questionnaire-based observational investigation. World J Urol. 2014; 32: 1021-1025.

  8. Ingela MCF, Stephan R et al. Nocturia and overactive bladder in obese women: a case-control study. Obesity Research & Clinical Practice. 2007; 1 (3): 187-193.

  9. Zhu J, Hu X, Dong X et al. Associations between risk factors and overactive bladder: a meta-analysis. Female Pelvic Med Reconstr Surg. 2019; 25 (3): 238-246.

  10. Zhu L, Cheng X, Sun J et al. Association between menopausal symptoms and overactive bladder: a cross-sectional questionnaire survey in China. PLoS One. 2015; 10: e0139599.

  11. Velasco DJEVMd. Estudio del climaterio y la menopausia. México: Colegio Mexicano de Especialistas en Ginecología y Obstetricia., 2010.

  12. Harlow SD, Gass M, Hall JE, Lobo R, Maki P, Rebar RW et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012; 97 (4): 1159-1168.

  13. Aikawa K, Sugino T, Matsumoto S et al. The effect of ovariectomy and estradiol on rabbit bladder smooth muscle contraction and morphology. J Urol. 2003; 170: 634-637.

  14. Lüthje A et al. Estrogenic action on innate defense mechanisms in the urinary tract. Maturitas. 2014; 77 (1): 32-36.

  15. Harlow SD, Gass M, Hall JE et al. Executive summary of the stages of reproductive aging workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012; 19: 387-395.

  16. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005; 112: 2735-2752.

  17. Grundy SM, Sephen RD et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, lung, and blood institute scientific statement. Circulation. 2005; 112: 2735-2752.

  18. Ahmad SM, Aznal SS, Tham SW. Prevalence of overactive bladder syndrome (OABS) among women with gynaecological problems and its risk factors in a tertiary hospital, Negeri Sembilan, Malaysia: Implication for primary healthcare providers. Malays Fam Physician. 2015; 10: 2-8.

  19. Al-Shaiji TF, Radomski SB. Relationship between body mass index and overactive bladder in women and correlations with urodynamic evaluation. Int Neurourol J. 2012; 16: 126-131.

  20. Alizadeh F, Zargham M, Nouri-Mahdavi K et al. Bladder involvement in thyroid dysfunction. J Res Med Sci. 2013; 18: 167.

  21. Jeter K, Blackwell S, Burke L et al. Cancer symptom scale preferences: does one size fit all? BMJ Support Palliat Care. 2018; 8: 198-203.




2020     |     www.medigraphic.com